Moreover, at the molecular and cellular level, our findings provide a novel approach to understanding the clinical data in which the 5-year survival time (after diagnosis) of the high p21 expression colon cancer cohort is greater than that of the low p21 expression colon cancer cohorts (Figure 6). The gene discussed is CDKN1A; the disease is malignant colon neoplasm.